FDA — authorised 25 November 1998
- Application: NDA020943
- Marketing authorisation holder: AZURITY
- Local brand name: VERELAN PM
- Indication: CAPSULE, EXTENDED RELEASE — ORAL
- Status: approved
FDA authorised verapamil controlled release on 25 November 1998
Yes. FDA authorised it on 25 November 1998.
AZURITY holds the US marketing authorisation.